Dada la enorme problemtica que supone el exceso de kilos, algunos pases han empezado a financiar Wegovy y Saxenda dentro de su sistema pblico de salud
1,3 A 2025 systematic review in the International Journal of Dermatology confirmed that among GLP-1 receptor agonists, semaglutide and tirzepatide showed the highest reported incidence of hair loss, with telogen effluvium and androgenetic alopecia (AGA) identified as the predominant subtypes
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for type 2 diabetes management
Gradual receptor activation helps the body adapt over time, supporting steadier energy, improved glucose balance, and reduced metabolic stress
Health Canada previously approved Ozempic to treat diabetes and Wegovy for weight loss
This form of resistance is generally associated with the accumulation of ROS and localized cell death in infected plant tissues